Abstract B117: From Epitranscriptomic to Metabolic Switch: PCIF1-Driven m6Am Modification Rewires Macrophage Lactate Metabolism to Orchestrate the Pancreatic Cancer Immune Microenvironment
Pancreatic cancer (PC) remains resistant to immune checkpoint inhibitors (ICIs) due to its profoundly immunosuppressive tumor microenvironment (TME), where tumor-associated macrophages (TAMs) predominantly adopt M2-like phenotypes. N6,2'-O-dimethyladenosine (m6Am) is a dynamic RNA modification at the messenger RNA (m...